International Journal of Diabetes Mellitus
Volume 2, Issue 2 , Pages 78-82 , August 2010

Association between metabolic syndrome and risk of cardiovascular disease, using different criteria and stratified by sex

  • Somlak Chuengsamarn

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, HRH Princess Maha Chakri Sirindhorn Medical Centre, Srinakharinwirot University, Thailand
    • Corresponding Author InformationCorresponding author. Address: Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, HRH Princess Maha Chakri Sirindhorn Medical Centre, Srinakharinwirot University, 63 Moo 7 Rungsit-Nakornnayok Rd., Ongkarak, Nakornnayok 26120, Thailand. Tel.: +66 37 395085 6x11001; fax: +66 37 395085 6x11003; mobile: +66 81 8367528.
    • ,
  • Suthee Rattanamongkoulgul

      Affiliations

    • Department of Preventive and Social Medicine, Faculty of Medicine, HRH Princess Maha Chakri Sirindhorn Medical Centre, Srinakharinwirot University, Thailand
    • ,
  • Alfredo Villarroel

      Affiliations

    • Department of Preventive and Social Medicine, Faculty of Medicine, HRH Princess Maha Chakri Sirindhorn Medical Centre, Srinakharinwirot University, Thailand

Received 4 March 2010 ,Accepted 19 May 2010.

References 

  1. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis of observational studies. Am J Med. 2006;119:812–819
  2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–2752
  3. Boyko E, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance. Diabetes Care. 2000;3:1242–1248
  4. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia. 1993;36:553–559
  5. Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chorn Dis. 1967;20:511–524
  6. Saito I, Folsom AR, Brancata FL, Duncan BB, Chambles LE, McGovern PG. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med. 2000;133:81–89
  7. Farrand ME, Mojonnier L. Nutrition in the multiple risk factor intervention trial (MRFIT). J Am Diet Assoc. 1980;76:347–351
  8. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359
  9. He J, Neal B, Gu D, Suriyawongpaisal P, Xin X, Reynolds R, et al. International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. Ethn Dis. 2004;14:260–268
  10. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–97.
  11. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf.
  12. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Diabet Med. 1998;15(7):539–553
  13. Ford ES. Risk for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769–1778
  14. Boehm BO, Claudi-Boehm S. The metabolic syndrome. Scand J Clin Lab Invest Suppl. 2005;240:3–13
  15. Choi KM, Lee KW, Seo JA, Oh JH, Kim SO, Kim NH, et al. Relationship between brachial–ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndrome. Diabetes Res Clin Pract. 2004;20:57–61
  16. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, et al. Brachial–ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003;26:615–622
  17. Nam JS, Park JS, Cho MH, Jee SH, Lee HS, Ahn CW, et al. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG. Diabetes Res Clin Pract. 2009;84:145–151
  18. Satoh H, Kishi R, Tsutsui H. Metabolic syndrome is a significant and independent risk factor for increased arterial stiffness in Japanese subjects. Hypertens Res. 2009;32:1067–1071
  19. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic Stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
  20. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039–1049
  21. Chiba Y, Saitoh S, Takagi S, Ohnishi H, Katoh N, Ohato J, et al. Relationship between visceral fat and cardiovascular disease risk factor: The Tanno and Sobetsu Study. Hypertens Res. 2007;30:229–236
  22. Sam S, Haffner S, Davidson MH, D’Agostino RB, Feinstein S, Kondos G, et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subject with type 2 diabetes. Diabetes Care. 2009;32:1916–1920
  23. Skilton MR, Moulin P, S’erusclat A, Nony P, Bonnet FA. A comparison of the NCEP-ATPIII, IDF and AHA/NHIBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis. 2007;190:416–422
  24. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
  25. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689
  26. Tseng CH, Tseng CP, Chong CK, Cheng JC, Tai TX. Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients. Int J Cardiol. 2006;111:80–85
  27. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis population-based prospective studies. J Cardiovasc Risk. 1996;3:213–219
  28. Rothman KJ, Greenland S. Types of epidemiologic studies. In:  Rothman KJ,  Greenland S editor. Modern epidemiology. Philadelphia: Raven-Lippincott Publishers; 1998;

PII: S1877-5934(10)00033-0

doi: 10.1016/j.ijdm.2010.05.011

International Journal of Diabetes Mellitus
Volume 2, Issue 2 , Pages 78-82 , August 2010

Article Tools